Andrew Rapkin

Andrew Rapkin is a seasoned investor and entrepreneur currently serving as the Lead Investor and Board Observer at CND Life Sciences and holding multiple roles including Investor/Consultant at Revert Technologies and Investor at CodeTogether Inc. Since 2014, Andrew has been the President of Remedios LLC, overseeing a portfolio of 22 companies within an opportunistic venture investment vehicle focused on seed and early-stage ventures in diverse sectors such as advanced manufacturing, eLearning, biotech, and SaaS. Additionally, Andrew is actively investing in various companies, including Fido, Upflex, Entelligent, Smart Access, Eventy, and CLICS. Academic qualifications include an MBA in Finance and Entrepreneurial Management from The Wharton School and a B.S. in Biology and Environmental Policy from Tufts University.